Esonarimod
CAS No. 101973-77-7
Esonarimod ( Esonarimod | KE-298 | KE298 )
产品货号. M17753 CAS No. 101973-77-7
艾索那莫德是一种抗风湿药。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥103 | 有现货 |
|
| 5MG | ¥164 | 有现货 |
|
| 10MG | ¥231 | 有现货 |
|
| 25MG | ¥453 | 有现货 |
|
| 50MG | ¥728 | 有现货 |
|
| 100MG | ¥1107 | 有现货 |
|
| 200MG | ¥1647 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥181 | 有现货 |
|
生物学信息
-
产品名称Esonarimod
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述艾索那莫德是一种抗风湿药。
-
产品描述Esonarimod is an antirheumatic drug, suppressing lymphocyte activating factor activity or biosynthesis.(In Vitro):Esonarimod (KE-298) (10 to 300 μg/mL) suppresses the production of NO by RAW264.7 cells in a dose dependent manner. The IC50 of Esonarimod is 117.5 μg/mL. Esonarimod does not affect cellular viability at these tested doses. Esonarimod has no direct effect on NOS activity in cell-free extracts of RAW264.7 cells.(In Vivo):After repeated oral administration of Esonarimod (14C-KE-298), the radioactivity decreases rapidly and no tendency towards accumulation is found.
-
体外实验——
-
体内实验——
-
同义词Esonarimod | KE-298 | KE298
-
通路Others
-
靶点Other Targets
-
受体IL-1
-
研究领域——
-
适应症——
化学信息
-
CAS Number101973-77-7
-
分子量280.34
-
分子式C14H16O4S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC1=CC=C(C=C1)C(=O)CC(CSC(=O)C)C(=O)O
-
化学全称Benzenebutanoic acid, alpha-((acetylthio)methyl)-4-methyl-gamma-oxo-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
2,4-Dihydroxy-6-meth...
2,4-Dihydroxy-6-methoxyacetophenone exhibits a moderate antispasmodic activity.
-
Neuropeptide Y (free...
Neuropeptide Y (human) free acid is the deamidated form of Neuropeptide Y (human, rat, mouse). The amidation of Neuropeptide Y C-terminal tyrosine is critical for its function. Non-amidated Neuropeptide Y fails to elicit G protein signaling.
-
N-Formyl-Met-Ala-Ser
N-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.N-Formyl-Met-Ala-Ser Peptide (fMet-Ala-Ser) binds to formyl peptide receptors on neutrophils. N-Formylmethionine-containing peptides including the most potent and known member, N-formyl-Met-Leu-Phe (FMLP or fMet-Leu-Phe) stimulate human neutrophils by a receptor-dependent mechanism.
021-51111890
购物车()
sales@molnova.cn

